Thus, despite well-defined differences in atherogenesis between mouse and humans, our results expand on recent genetic association studies and put forward several lines of evidence warranting future investigation into a definitive role for Treml4 in cardiovascular disease. The gene discussed is TREML4; the disease is cardiovascular disorder.